Hemab Therapeutics Holdings, Inc. Common Stock

NASDAQ:COAG

Biotechnology

Healthcare
$39.15 +8.79%

+$2.32 today

Market cap
$1.83B
Beta
0.00
52W Low $23.00High $36.61

Volume 0.30M

Average 0.34M

COAG Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

No reported Gross Margin figures are available to summarize.

Gross Margin history

Percent of revenue · from the income statement

No Gross Margin data reported for this period type.

Gross Margin vs competitors

How COAG compares with its peers on the latest reported figures

COAG Competitors Peer median
Gross Margin for COAG and competitors
Company Period LTM level YoY 3-year change
RLYBRallybio CorporationLTM Mar 202699.7% +7.2 pp—
QUREuniQure N.V.LTM Mar 202674.1% +20.2 pp-7.3 pp
COAGHemab Therapeutics Holdings, Inc. Common StockFY2025— ——
IRONDisc Medicine, Inc.FY2025— ——
DMRADamora Therapeutics, Inc.FY2025— ——
Peer median (excluding COAG) 86.9%+13.7 pp-7.3 pp

Competitors are the stored peer set for COAG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Hemab Therapeutics Holdings, Inc. Common Stock

NASDAQ:COAG

Intrinsic Alpha fair value

Locked

Current Price

$39.15

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.